NovoCure (NVCR) Return on Equity [ROE] (2015 - 2026)
NovoCure's Return on Equity [ROE] came in at -44.43% for Q2 2026, up 3.63 percentage points from -48.06% a year earlier and up 7.14 percentage points from the prior quarter.
Powered by 
Analysis
NovoCure (NVCR) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, NovoCure's Return on Equity [ROE] was -38.89%, up 7.78 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -44.59 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -46.67% in FY2024 (+4.86 pp), -51.52% in FY2023 (-29.79 pp), -21.73% in FY2022 (-8.57 pp) and -13.16% in FY2021 (-18.86 pp).
- The five-year range for quarterly Return on Equity [ROE] is -54.76% (Q4 2023) to -6.66% (Q3 2021).
- Year-over-year, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +2.04 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2024 (a gain of 7.98 percentage points), and the weakest in Q4 2023 (a drop of 33.88 percentage points).
- Business Quant data shows NVCR's Return on Equity [ROE] at -51.56% (Q1 2026), -39.96% (Q4 2025) and -51.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 3.88% |
| 10 | NovoCure | 1.74 Bn | -614.09 Mn | 142.48 Mn | -44.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.43% |
| Mar 31, 2026 | -51.56% |
| Dec 31, 2025 | -39.96% |
| Sep 30, 2025 | -51.44% |
| Jun 30, 2025 | -48.06% |
| Mar 31, 2025 | -45.47% |
| Dec 31, 2024 | -46.78% |
| Sep 30, 2024 | -41.46% |
| Jun 30, 2024 | -46.79% |
| Mar 31, 2024 | -53.40% |
| Dec 31, 2023 | -54.76% |
| Sep 30, 2023 | -48.74% |
| Jun 30, 2023 | -41.13% |
| Mar 31, 2023 | -32.28% |
| Dec 31, 2022 | -20.87% |
| Sep 30, 2022 | -18.42% |
| Jun 30, 2022 | -15.55% |
| Mar 31, 2022 | -13.91% |
| Dec 31, 2021 | -14.17% |
| Sep 30, 2021 | -6.66% |
API Access
NovoCure Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NVCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();